Skip to main content

Table 1 Pharmacokinetic parameters of N-251 after intravenous administration in mice

From: Pharmacokinetic analysis of new synthetic antimalarial N-251

Dose (mg/kg)

Pharmacokinetic parameters

AUCiv (ng/mL·h)

CLtotal (L/h/kg)

kel (h−1)

Vd1 (L/kg)

Vd2 (L/kg)

Vdss (L/kg)

MRTiv (h)

A (ng/mL)

a (h−1)

B (ng/mL)

b (h−1)

5

1161.50

4.30

1.33

3.23

1.62

4.85

1.12

1453.6 ± 465.9

1.62 ± 0.70

92.5 ± 182.0

0.35 ± 0.37

10

2433.64

4.11

2.60

1.58

2.35

3.93

0.96

5922.7 ± 1731.5

3.84 ± 1.23

410.0 ± 253.8

0.46 ± 0.15

25

7455.60

3.35

2.47

1.36

1.52

2.88

0.86

17,738.1 ± 1700.0

3.12 ± 0.55

690.4 ± 341.6

0.39 ± 0.10

  1. Pharmacokinetic parameters were calculated using the equations described in the “Methods” section. A, B, a, and b are hybrid parameters in the equation describing the plasma concentration-time profile after intravenous administration, and they were expressed as SD